Search for products, methods, support...
All Instruments
Cost-efficient flexibility for new and emerging applications.
All Kits & Reagents
Reagent kits for the NovaSeq 6000 System provide ready-to-use cartridge-based reagents for cluster generation and SBS
All Selection & Planning Tools
Compare sequencing systems and find the right one for your lab or application
All Software & Informatics Products
Call, prioritize, and report on variants from one interface
All Services
Verify instrument installation and operation, obtain an audit-ready report
All Popular Products
Find popular product groupings designed for your workflow
A rapid, sensitive method for profiling accessible chromatin across the genome
All Techniques
All Technologies
All Training
All Informatics Education
More About Us
By Dr. Phil Febbo, Chief Medical Officer at Illumina
More Career Info
All Investor Information
More Business Solutions
All Legal Information
Upgrade solution for Illumina systems
All Support Tools
All Product Support Services
All Contact Info
The Breast Cancer Atlas Project is sequencing more than a million breast cancer cells with the NovaSeq 6000 System
All Cancer Genomics Products
More Tools
All Microbial Genomics Research
Learn about eDNA through sequencing the seas
All Microbial Genomics Products
All Informatics Products
More News
International Mungbean Improvement Network Wins Grant
Uncover how chromatin packaging and other factors affect gene expression
All Complex Disease Research Products
TBD
Dr. Phil Febbo, SVP and Chief Medical Officer
All Reproductive Health
Two next-generation sequencers now available for in vitro diagnostics
Assay targeting multiple variant types, including tumor mutational burden (TMB) and microsatellite instability (MSI), even from low-quality samples.
Scalable throughput and flexibility for virtually any genome, sequencing method, and scale of project.
Microbiology
Happy Monday, everyone!
